Deferiprone
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB08826 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 36 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | hepatic porphyria | KG + DL |
| 2 | hepatopulmonary syndrome | KG + DL |
| 3 | idiopathic copper-associated cirrhosis | KG + DL |
| 4 | primitive portal vein thrombosis | KG + DL |
| 5 | early-onset familial noncirrhotic portal hypertension | KG + DL |
| 6 | hepatoportal sclerosis | KG + DL |
| 7 | pyruvate kinase deficiency of red cells | KG + DL |
| 8 | beta-thalassemia with other manifestations | KG + DL |
| 9 | pyropoikilocytosis, hereditary | KG + DL |
| 10 | partial deletion of the short arm of chromosome 16 | KG + DL |
| 11 | hemolytic anemia due to glucophosphate isomerase deficiency | KG + DL |
| 12 | chronic hepatitis C virus infection | KG + DL |
| 13 | obsolete familial combined hyperlipidemia | KG + DL |
| 14 | HIV infectious disease | KG + DL |
| 15 | familial hyperlipidemia | KG + DL |
| 16 | homozygous familial hypercholesterolemia | KG + DL |
| 17 | neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter | KG + DL |
| 18 | paratenonitis | KG + DL |
| 19 | calcific tendinitis | KG + DL |
| 20 | feline acquired immunodeficiency syndrome | KG + DL |
| 21 | simian immunodeficiency virus infection | KG + DL |
| 22 | glycogen storage disease due to hepatic glycogen synthase deficiency | KG + DL |
| 23 | Heiner syndrome | KG + DL |
| 24 | myositis | KG + DL |
| 25 | selective IgG subclass deficiency | KG + DL |
| 26 | hepatitis B virus infection | KG + DL |
| 27 | African iron overload | KG + DL |
| 28 | coronary stenosis | KG + DL |
| 29 | neonatal hemochromatosis | KG + DL |
| 30 | hemosiderosis, pulmonary, with deficiency of gamma-a globulin | KG + DL |
| 31 | hypoglycemia | KG + DL |
| 32 | chronic hepatitis B virus infection | KG + DL |
| 33 | familial hypercholesterolemia | KG + DL |
| 34 | hepatitis C virus infection | KG + DL |
| 35 | hypercholesterolemia, autosomal dominant | KG + DL |
| 36 | selective IgG immunodeficiency | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.